161 related articles for article (PubMed ID: 24898571)
1. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department.
Lindner G; Funk GC; Leichtle AB; Fiedler GM; Schwarz C; Eleftheriadis T; Pasch A; Mohaupt MG; Exadaktylos AK; Arampatzis S
Int J Clin Pract; 2014 Nov; 68(11):1352-7. PubMed ID: 24898571
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
Hughes J; Y Y Chiu D; Kalra PA; Green D
PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
[TBL] [Abstract][Full Text] [Related]
4. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
[TBL] [Abstract][Full Text] [Related]
6. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
7. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.
Kieboom BCT; Zietse R; Ikram MA; Hoorn EJ; Stricker BH
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1166-1173. PubMed ID: 30095199
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
9. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
[TBL] [Abstract][Full Text] [Related]
10. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
[TBL] [Abstract][Full Text] [Related]
11. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
12. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
Cundy T; Dissanayake A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
[TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
[TBL] [Abstract][Full Text] [Related]
16. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
[TBL] [Abstract][Full Text] [Related]
17. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
[TBL] [Abstract][Full Text] [Related]
19. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.
Koulouridis I; Alfayez M; Tighiouart H; Madias NE; Kent DM; Paulus JK; Jaber BL
Am J Kidney Dis; 2013 Oct; 62(4):730-7. PubMed ID: 23664547
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
